During the past decade, Vanderbilt University Schizophrenia Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Vanderbilt University Schizophrenia Research" are "Schizophrenia" (2 trials). Many other conditions were trialed in "Vanderbilt University Schizophrenia Research" in a lesser frequency.

Most popular intervention types in "Vanderbilt University Schizophrenia Research" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Metformin" (1 trials), "Placebo" (1 trials), "clozapine" (1 trials), "fluphenazine decanoate" (1 trials) and "olanzapine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vanderbilt University Schizophrenia Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Vanderbilt University Schizophrenia Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Vanderbilt University Schizophrenia Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vanderbilt University Schizophrenia Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".